Case 3. Melanoma-associated retinopathy presenting with night blindness

Journal of Clinical Oncology

Volumn 22, Issue 4, 2004, Pages 747-748

  Myers, Doreen A ^a   Bird, Brian R ^a   Ryan, Susan M ^a   Tormey, Peter ^a   McKenna, Paul ^a   O'Reilly, Seamus ^a   Breathnach, Oscar S ^a  

^a Department of Medicine National University of Ireland Cork

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DISEASE ASSOCIATION; DRUG TOLERABILITY; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MALE; MELANOMA; NIGHT BLINDNESS; PIGMENT DISORDER; PRIORITY JOURNAL; RETINOPATHY;

EID: 23244437972     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.05.036     Document Type: Article

References (6)

1. Balch CM, et al: Final version of the American Joint Committee on Cancer staging system for cutaneous Melanoma. J Clin Oncol 19:3635-3648, 2001
2. Berson EL, Lessell S: Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol 106:307-311, 1988
3. Chan JW: Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 48:12-38, 2003
4. Milam AH, Saari JC, Jacobson SG, et al: Autoantibodies against retinal bipolar cells in cutaneous melanoma-associated retinopathy. Invest Ophthalmol Vis Sci 34:91-100, 1993
5. Milam AH. Clinical aspects: Paraneoplastic retinopathy, in Djamgoz MBA, Archer SN, Vallerga S (eds): Neurobiolgy and Clinical Aspects of the Outer Retina. London, United Kingdom, Chapman and Hall, 1995, pp 461-471
6. Keltner JL, Thirkill CE, Yip PT: Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: Eleven new cases and a review of 51 previously published cases. J Neuroophthalmol 21:173-187, 2001